NELARABINE
NDC 46708-813, nelarabine, injection, from Alembic Pharmaceuticals Limited.
- Product NDC
- 46708-813
- Status
- Listed
- Labeler
- Alembic Pharmaceuticals Limited
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218554
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/46708-813 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NELARABINE5 mg/mL
Pharmacologic classes
Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 46708-813-50 | 46708081350 | 1 VIAL in 1 CARTON (46708-813-50) / 50 mL in 1 VIAL |
| 46708-813-63 | 46708081363 | 6 VIAL in 1 CARTON (46708-813-63) / 50 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/03ad6056-0e71-4e7c-842a-a5f87649bdcd
Use it
Look up 46708-813 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/46708-813 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 46708-813. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.